Literature DB >> 8415358

Chicken antibodies: taking advantage of evolution--a review.

A Larsson1, R M Bålöw, T L Lindahl, P O Forsberg.   

Abstract

Laying hens are highly cost-effective as producers of antibodies compared with the mammals traditionally used for such production. Also, chicken antibodies have biochemical advantages over mammalian antibodies due to the phylogenetical differences between avian and mammalian species, resulting in increased sensitivity as well as decreased background in immunological assays. In contrast to mammalian antibodies, chicken antibodies do not activate the human complement system nor will they react with rheumatoid factors, human anti-mouse IgG antibodies, or bacterial and human Fc (fragment crystallizable)-receptors. Thus, chicken antibodies offer many advantages over mammalian antibodies and may replace such antibodies in the future.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415358     DOI: 10.3382/ps.0721807

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  32 in total

Review 1.  Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases.

Authors:  Shofiqur Rahman; Sa Van Nguyen; Faustino C Icatlo; Kouji Umeda; Yoshikatsu Kodama
Journal:  Hum Vaccin Immunother       Date:  2013-01-14       Impact factor: 3.452

2.  Generation and characterization of polyclonal antibody against part of immunoglobulin constant heavy υ chain of goose.

Authors:  Panpan Zhao; Yongli Guo; Bo Ma; Mingwei Xing; Junwei Wang
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-08

3.  Improved immunoassay for the detection of severe combined immunodeficiency.

Authors:  David K Janik; Barbara Lindau-Shepard; Bent Nørgaard-Pedersen; Carsten Heilmann; Kenneth A Pass
Journal:  Clin Chem       Date:  2011-05-13       Impact factor: 8.327

Review 4.  Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections.

Authors:  D Carlander; H Kollberg; P E Wejåker; A Larsson
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  Ostrich produce cross-reactive neutralization antibodies against pandemic influenza virus A/H1N1 following immunization with a seasonal influenza vaccine.

Authors:  Kazuhide Adachi; Kentaro Takama; Masaya Tsukamoto; Marie Inai; Ekowati Handharyani; Satoshi Hiroi; Yasuhiro Tsukamoto
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

6.  Expression of α-subunit of α-glucosidase II in adult mouse brain regions and selected organs.

Authors:  Antje Anji; Hayley Miller; Chandrasekar Raman; Mathew Phillips; Gary Ciment; Meena Kumari
Journal:  J Neurosci Res       Date:  2014-08-18       Impact factor: 4.164

Review 7.  Passive immune neutralization strategies for prevention and control of influenza A infections.

Authors:  Jianqiang Ye; Hongxia Shao; Daniel R Perez
Journal:  Immunotherapy       Date:  2012-02       Impact factor: 4.196

8.  Study on development of Vipera lebetina snake anti-venom in chicken egg yolk for passive immunization.

Authors:  Hossein Zolfagharian; Naser Mohammadpour Dounighi
Journal:  Hum Vaccin Immunother       Date:  2015-02-20       Impact factor: 3.452

9.  Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice.

Authors:  Huan H Nguyen; Terrence M Tumpey; Hae-Jung Park; Young-Ho Byun; Linh D Tran; Van D Nguyen; Paul E Kilgore; Cecil Czerkinsky; Jacqueline M Katz; Baik Lin Seong; Jae Min Song; Young Bong Kim; Hoa T Do; Tung Nguyen; Cam V Nguyen
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

10.  Measurement of urinary cystatin C with a particle-enhanced turbidimetric immunoassay on Architect ci8200.

Authors:  Feria Hikmet Noraddin; Mats Flodin; Annika Fredricsson; Azita Sohrabian; Anders Larsson
Journal:  J Clin Lab Anal       Date:  2012-09       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.